Minneapolis Heart Institute Foundation

Advanced Heart Failure Research

August 2025 Semi-Annual Update

View as Webpage

News & Accomplishments

Course on Management of Cardiogenic Shock & Heart Recovery

  • Hosted by MHI Advanced Heart Failure and Critical Care Cardiology teams
  • MHI faculty in cardiology, cardiac surgery, pharmacy, nursing, critical care, palliative care, and administration
  • Participants from 14 centers
  • Sponsored by J&J

First Half of 2025:


14 publications


10 Podium & Poster Presentations 


HF RA & 2025 Interns

Melanie Sun, Research Associate


Melanie recently joined the team and will support HF investigator-initiated research projects. She was a 2024 Intern at MHIF.

Julia Harris, 2025 Intern


Mentor: Dr. Siu-Hin Wan

Project: Clinical and Echocardiographic Changes with Treatment for ATTR-CM 

Pranoy Sangowdar, 2025 Intern


Mentor: Dr. Steve Bradley

Project: Initial diuretic dosing in the emergency department among patients admitted for heart failure

Study Spotlight: CORCINCH-HF


Description

Study evaluating the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with HFrEF.



Enrolling Patients with:

  • LVEF ≥20% and ≤40%
  • LVEDD ≥ 55 mm
  • NYHA Class III, ambulatory IV, or II with HF hospitalization within 12 months
  • On stable GDMT

Principal Investigator:

Dr. Peter Eckman


Contact:

Kate Jappe

Kate.Jappe@allina.com

Phone: (612) 863-5855

Recruiting Studies

Surgical & VAD

Studies

Description

PI & Enrolling Sites

INNOVATE

BrioHealth Solutions

Safety and efficacy of the BrioVAD System vs. HeartMate 3 Left Ventricular Assist System

Dr. Benjamin Sun


ANW

OHP Registry ll

Transmedics

Clinical outcomes of heart transplant recipients that used the Organ Care Heart Perfusion System

Dr. Benjamin Sun


ANW

Interventional Heart Failure

ALLAY-HF

Alleviant Medical

No-implant interarterial shunt in patients with HFpEF

Dr. Peter Eckman


ANW & United

ALT-FLOW ll

Edwards Lifesciences

Transcatheter interarterial shunt in patients with HFpEF

Dr. Mike Samara


ANW

CorCinch-HF

Ancora Heart

AccuCinch Ventricular Restoration System in patients with HFrEF

Dr. Peter Eckman


ANW

GenePHIT/ASK-CHF 2

AskBio

Gene therapy trial for patients with non-ischemic NYHA Class III symptoms of Heart Failure

Dr. Jay Traverse


ANW

Outpatient & Drug

CONTEMP-ICD

U of Rochester

Benefit and risks of ICD implantation in patients with HF who have a low risk of sudden death

Dr. Mosi Bennett


ANW

Electrophysiology

AIM HIGHer

Impulse Dynamics

Cardiac contractility modulation in HFpEF

Dr. Mike Samara


ANW

Peripartum

REBIRTH

U of Pittsburgh / NIH

Impact of bromocriptine on clinical outcomes for peripartum cardiomyopathy

Dr. Retu Saxena


ANW

Pipeline Studies

FASTR ll

Reprieve Cardiovascular

Fluid management of acute decompensated heart failure subjects treated with Reprieve System

Dr. David Miranda


ANW

REDEFINE-HF

Colorado Prevention Center

Finerenone for the treatment of hospitalized patients with HFmrEF or HFpEF

Dr. Mosi Bennett


ANW

INTeGRATE

Abiomed

Initiation and titration of GDMT in HF cardiogenic shock with Impella 5.5 for cardiac recovery

Dr. Kasia Hryniewicz


ANW

TEAM-HF

Abbott

LVAD vs continued GDMT in non-inotrope dependent HF patients with refractory pulmonary hypertension secondary to LV heart failure

Dr. Mosi Bennett


ANW

ANW=Abbott Northwestern; GDMT=Guideline-Directed Medical Therapy; HFmrEF=Heart Failure with Mildly Reduced Ejection Fraction HF=Heart Failure; HFpEF=Heart Failure with Preserved Ejection Fraction; HFrEF=Heart Failure with Reduced Ejection Fraction; ICD=Implantable Cardioverter-Defibrillator; J&J=Johnson & Johnson; LVAD=Left Ventricular Assist Device; LVEDD=Left Ventricular End-Diastolic Diameter; LVEF=Left Ventricular Ejection Fraction; NIH=National Institutes of Health; NYHA=New York Heart Association; OHP=Organ Care Heart Perfusion System; PI=Principal Investigator; VAD=Ventricular Assist Device


For more information, please contact Julianne Feola at julianne.Feola@allina.com; Ph: (585)944-8268


Interested in clinical trials from our other areas of cardiovascular research? Visit mplsheart.org/archive for any recent emails you may have missed.